Tag: NICE
UK's NICE rejects Glaxo, Genmab leukemia drug
by on Jul.02, 2010, under Health and Fitness
GlaxoSmithKline leukemia drug Arzerra, licensed from Denmark's Genmab, has been rejected by Britain's cost watchdog NICE in preliminary draft guidance.
View full post on Yahoo! Health News